Hartmuth C. Kolb

Company: Enigma Biomedical Group

Job title: Chief Scientific Officer

Seminars:

Precision Medicine in Alzheimer’s Disease – Neuroimaging 11:30 am

Discuss how Amyloid and Tau imaging have contributed to development of the Biomarker-driven NIA-AA framework that classifies individuals in an unbiased symptom-agnostic fashion based on key AD-pathophysiological changes Provide specific examples for Tau and Amyloid PET imaging in the NIA-AA context Deep dive into Amyloid PET with NAV4694Read more

day: Clinical & Commercial Track AM